Journals / Turkish Journal of Urology / 2015 / Cilt: 41 - Sayı: 1

Böbrek hücreli kanser nedeniyle radikal nefrektomi yapılan hastalarda preoperatif görüntüleme ve postoperatif patoloji bulgularının sağkalım tahminindeki önemi

Impact of preoperative radiological and postoperative pathological findings on survival of patients after radical nephrectomy performed with the indication of renal cell carcinoma

Pages
1–6
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We found radiological lymph node involvement and stage of the disease as independent factors affecting the survival of RCC patients after radical nephrectomy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the impact of preoperative radiological and postoperative pathological findings on survival of patients after radical nephrectomy because of renal cell carcinoma (RCC).
📊
Key Findings & Data:Material and methods: We performed 159 consecutive radical nephrectomy operations between December 2007 and January 2014.
💡
Conclusion & Impact:Conclusion: We found radiological lymph node involvement and stage of the disease as independent factors affecting the survival of RCC patients after radical nephrectomy.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the impact of preoperative radiological and postoperative pathological findings on survival of patients after radical nephrectomy because of renal cell carcinoma (RCC). Material and methods: We performed 159 consecutive radical nephrectomy operations between December 2007 and January 2014. We evaluated age, gender, complaints, operation time, comorbidity, computed tomogra- phy (CT) and magnetic resonance graphy (MRG) results. Size of the mass, lymph node involvement, renal vein invasion, and presence of metastases were investigated. During histopathological examination, especially, patho- logical diagnosis, subtypes of RCC, lymph node involvement, lymphovascular, perineural invasion, and capsular, renal pelvis invasion, and renal vein involvement were sought. Follow-up periods of the patients were determined based on dates of death of the patients, and the study period. Results: RCC was seen in 124 (78%) of patients. Mean estimated suvival of RCC patients was 60 months and 5 year survival was 64%. Tumor size greater than 6.5 cm, lymph node involvement (p=0.006) and bölmeyelimj metastasis in radiological results (p<0.001), lymphovascular invasion (p=0.015) and stage of disease (p<0.001) found to be significantly affecting the survival. Lymph node involvement in radiological results (p=0.0089; HR: 4.6; CI 95%: 1.4753 -14.3523) and stage of the disease (p=0.0129; HR: 1.6; CI 95%: 1.1087-2.3461) were affecting the survival independently. Conclusion: We found radiological lymph node involvement and stage of the disease as independent factors affecting the survival of RCC patients after radical nephrectomy.

Özet

Amaç: Böbrek hücreli kanser (BHK) tanısıyla radikal nefrektomi yapılan hastalarda preoperatif görüntül- eme ve postoperatif patoloji sonuçlarının sağkalım tahmindeki etkilerinin araştırılması. Gereç ve yöntemler: Aralık 2007 ile Ocak 2014 tarihleri arasında radikal nefrektomi uyguladığımız ardışık 159 hastanın yaş, cinsiyet, şikayet, operasyon tarihi, komorbidite, bilgisayarlı tomografi (BT) ve manyetik rezonans görüntüleme (MRG) sonuçlarına ulaşıldı. Radyolojik incelemelerde kitlenin boyut, lenf düğümü tutulumu, renal ven invazyonu ve metastaz varlığı araştırıldı. Patoloji sonuçlarında patolojik tanı, BHK ise alt tipleri, lenf düğümü tutulumu, lenfovasküler invazyon, perinöral invazyon, kapsül invazyonu, renal pelvis invazyonu, renal ven tutulumuna dikkat edildi. Hastaların ölüm tarihlerine ve çalışma tarihine göre takip süreleri hesaplandı. Bulgular: Radikal nefrektomi yapılan 159 hastanın 124ünde (%78) BHK görüldü. BHKde ortalama tah- mini sağkalım 60 ay iken 5 yıllık sağkalım %64 olarak hesaplandı. Tümör boyutunun 6,5 cmden büyük olması, görüntüleme yöntemlerinde lenf düğümü pozitifliği (p=0.006) ve metastaz varlığı (p<0,001), pa- tolojik değerlendirmede lenfovasküler invazyon (p=0,015) ve hastalığın evresi(p<0,001) sağkalıma anlamlı olarak etki eden faktörler olarak bulundu. Görüntülemede lenf düğümü pozitifliği (p=0,0089; HR: 4,6; CI %95: 1,4753 -14,3523) ve hastalığın evresi (p=0,0129; HR: 1,6; CI %95: 1,1087-2,3461) sağkalımda tek başına etki eden faktörler olarak bulundu. Sonuç: Çok değişkenli analizlerde görüntülemede lenf düğümü saptanması ve tümörün evresi sağkalımın tahmininde bağımsız faktörler olarak saptandı.

🔖

Cite This Article

ŞİMŞEK, A., KÜÇÜKTOPCU, E., KÜÇÜKTOPÇU, O., AKBULUT, F., ÖZGÜR, F., SAVUN, M., BERBEROĞLU, Y., GÜRBÜZ, G. (2015). Böbrek hücreli kanser nedeniyle radikal nefrektomi yapılan hastalarda preoperatif görüntüleme ve postoperatif patoloji bulgularının sağkalım tahminindeki önemi. Turkish Journal of Urology, Cilt: 41 - Sayı: 1, 1–6. https://ajindex.com/articles/379932

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Srinvasan R, Linehan WM. Treatment of advanced renal cell car- cinoma. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell–Walsh Urology, chap 50, vol 2, 10th edn. Saunders, Philadelphia, 2002.p.1475-91
  2. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol 2006;176:2353-8. [CrossRef] 3. Jayson M, Sanders H. Increased incidence of serendipitously dis- covered renal cell carcinoma. Urology 1998;51:203-5. [CrossRef] 4. Lee CT, Katz J, Fearn PA, Russo P. Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol 2002;7:135-40. [CrossRef] 5. Kim HL, Belldegrun AS, Freitas DG, Bui MH, Han KR, Dorey FJ, et al. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis. J Urol 2003;170:1742-6. [CrossRef] 6. Israel GM, Bosniak MA. How I do it: evaluating renal masses. Radiology 2005;236:441-50. [CrossRef] 7. Capitanio U, Cloutier V, Zini L, Isbarn H, Jeldres C, Shariat SF, et al. A critical assessment of the prognostic value of clear cell, papil- lary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int 2009;103:1496-500. [CrossRef] 8. Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML, et al. Histological subtype is an independent pre- dictor of outcome for patients with renal cell carcinoma. J Urol 2010;183:1309-15. [CrossRef] 9. European Network of Cancer Registries. European Network of Cancer Registries; Lyon: 2001. Eurocim version 4.0. European incidence database V2.3, 730 entity dictionary
  3. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treat- ment effect. J Natl Cancer Inst 2006;98:1331-4. [CrossRef] 11. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, et al. The Heidelberg classification of renal cell tumours. J Pathol 1997;183:131-3. [CrossRef] 12. Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma- age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology 2000;56:58-62. [CrossRef] 13. Patard JJ, Rodriguez A, Rioux-Leclercq N, Guillé F, Lobel B. Prognostic significance of the mode of detection in renal tumours. BJU Int 2002;90:358-63. [CrossRef] 14. Bensalah A, Bex S, Canfield S, Dabestani F, Hofmann M, Hora MA, et al. Guidelines on Renal Cell Carcinoma. Update April 2014.p.23
  4. Sene AP, Hunt L, McMahon RF, Carroll RN. Renal c